default author photo

Zhe Yang

Nanjing Medical University

300 Guangzhou Road

Nanjing, 210029

China

SCHOLARLY PAPERS

1

DOWNLOADS

50

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Adjuvant Chemotherapy Confers Survival Benefit Only in High-Risk Pathologic Stage I Non-Squamous NSCLC: A Multicenter Prospective Cohort Study and Machine-Learning–Based Decision Tool

Number of pages: 29 Posted: 31 Oct 2025
Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University, Nanjing Medical University - Molecular Diagnostic Laboratory of Tumor, Friendship Hospital of Ili Kazakh Autonomous Prefecture, Suzhou Xiangcheng People's Hospital - Comprehensive Cancer Center, Nanjing University, Nanjing University and Nanjing Medical University
Downloads 50 (1,063,489)

Abstract:

Loading...

Adjuvant chemotherapy, Stage I, Non-small cell lung cancer, High-risk factor, Prediction model